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Figure S1. Development of an assay to monitor protein degradation. Related to Figure 1 (A) in vitro ubiquitination of 
GST-Wbp2 with Ube1, UbcH5a and Rsp5-E6AP at room temperature. Reactions were fractionated by SDS-PAGE and 
analyzed using a Typhoon fluorescence scanner at different time points as indicated. (B) Proteasomal degradation of UbnGST–
Wbp2. 20 nM K48UbnGST–Wbp2 was incubated with 2.5 nM 26S proteasome at 37˚C for 2 hours in the absence and presence 
of different inhibitors (20 µM CZM or 5 µM epoxomicin/Epox or 1 mM AMP-PNP). Reactions were fractionated by SDS-
PAGE and analyzed using a Typhoon fluorescence scanner. (C) Measurement of proteasome activity using fluorescence 
polarization assay. K48UbnGST–Wbp2 (2.5 nM) was incubated with 1 nM 26S proteasome at 37 °C in the absence or presence 
of different inhibitors (10 µM Epox or 2 mM ATPγS or 2 mM 1,10-phenanthroline (1,10-PT)). (D) Epoxomicin inhibits the 
degradation of the Wbp2 substrate. Shown is the dose-response curve of proteasome activity measured at 37 °C using 
UbnGST–Wbp2 as substrate and proteasome with different concentrations of epoxomicin.  (E) Shown are the dose-response 
curves of proteasome activity measured at 37°C using UbnGST–Wbp2 as substrate and proteasome in the presence of different 
concentrations of K48-linked Ub4. (F) Shown is the reaction kinetics measured at 37 °C using K63UbnGST–Wbp2 as substrate 
and lysate from cells treated with different concentrations of carfilzomib.  
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Figure S2. Effects on the cell morphology. Related to Figure 4. Shown are microscopic images of HCT116 cells, taken 3 
hours after treatment with 10 µM of the indicated compounds except for BTZ, which was used at 1 µM. 
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Figure S3. Screening the effects of ETPs on the degradation of IκBα in TNF-α-stimulated Hela cells. Related to Figure 4. 
Hela cells were stimulated with TNF-α for 30 mins in the presence of 1 µM compounds as indicated. Degradation of IκBα was 
evaluated by western blot.  
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Figure S4. ETP showed little effect on stabilization of multiple proteasome substrates. Related to Figure 4. HCT116 cells 
were incubated with either ETP compounds (10 µM), CZM (10 µM), or BTZ (1 µM) for 6 hours, and cell lysates were 
fractionated by SDS–PAGE and immunoblotted with antibodies against c-Myc, MDM2, p53 or GAPDH.  
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K63 (%) K48 (%) K33 (%) K29 (%) K27 (%) K11 (%) K6 (%) 
K63UbnGST-
Wbp2 
94.13±0.28 1.69±0.06 0.34±0.03 2.13±0.03 0.04±0.01 1.49±0.16 0.19±0.02 
K48UbnGST-
Wbp2 
5.29±0.06 87.18±1.60 0.22±0.03 Not 
detected 
0.03±0.00 3.78±0.27 3.52±0.67 
 
Table S1. Mass spectrometry characterization of the polyubiquitinated GST-Wbp2. Related to Figure 1. 
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Reference Structure Rpn11  IC50 (µM) 
Csn5    
IC50 (µM) 
AMSH  
IC50 (µM) 
UbG76VGFP  
IC50 (µM) 
GI50 
(µM) 
SOP1 
 
2.6±0.6 0.2±0.06 0.6±0.04 5.7±0.6 8.6±2.0 
SOP2 
 
1.1±0.3 1.2±0.3 3.2±0.2 10.7±1.6 >20 
SOP3 
 
1.3±0.4 0.4±0.1 0.5±0.04 5.0±0.8 5.7±1 
SOP4 
 
0.2±0.05 0.5±0.1 0.3±0.04 14.6±3.1 5.8±1 
SOP5 
 
3.1±1.0 0.7±0.3 1.0±0.1 8.0±1.1 >20 
SOP6 
 
3.8±1.2 2.9±0.5 2.1±0.2 4.6±1.2 1.4±0.1 
SOP7 
 
>100 >100 >100 >50 >100 
SOP8 
 
3.7±1 1.2±0.2 0.9±0.04 >20 >20 
SOP9 
 
1.9±0.4 0.9±0.3 0.4±0.03 >20 >20 
SOP10 
 
0.7±0.2 0.6±0.2 1.0±0.04 4.6±1.1 8.2±1.0 
SOP11 
 
1.3±0.3 0.6±0.2 0.9±0.1 2.7±0.7 4.7±0.5 
Gliotoxin 
 
6.9±3.4 14±3 3.6±0.6 0.4 0.3±0.04 
Table S2. Summary table of the ETPs. Related to Figure 3 and Figure 5. 
